绝经后激素治疗：现状
Postmenopausal hormonal therapy: Current status.
作者信息
Jyotsna V P
机构信息
Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India.
出版信息
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S45-9. doi: 10.4103/2230-8210.119504.
Abstract
Many trials of the pros and cons of postmenopausal hormone replacement therapy have been done and this treatment has evolved over time. Here, we present a review and current status of this therapy.
摘要
关于绝经后激素替代疗法的利弊，已经进行了许多试验，并且这种治疗方法也随着时间不断发展。在此，我们对这种疗法进行综述并介绍其当前状况。
相似文献
1
Postmenopausal hormonal therapy: Current status.绝经后激素治疗：现状
Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S45-9. doi: 10.4103/2230-8210.119504.
2
Hormone replacement therapy and stroke: clinical trials review.激素替代疗法与中风：临床试验综述
Stroke. 2004 Nov;35(11 Suppl 1):2644-7. doi: 10.1161/01.STR.0000143218.20061.ac. Epub 2004 Sep 30.
3
Beneficial effects of hormonal replacement therapy on chromium status and glucose and lipid metabolism in postmenopausal women.激素替代疗法对绝经后女性铬状态及糖脂代谢的有益作用。
Maturitas. 2002 May 20;42(1):63-9. doi: 10.1016/s0378-5122(02)00003-8.
4
Women at midlife. Hormone replacement therapy.中年女性。激素替代疗法。
Nurs Clin North Am. 1992 Dec;27(4):959-69.
5
Postmenopausal hormone therapy: the pros and cons.绝经后激素治疗：利弊
Intern Med J. 2004 Mar;34(3):109-14. doi: 10.1111/j.1444-0903.2004.00555.x.
6
Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women.激素替代疗法对健康绝经后女性生长激素分泌模式及身体测量参数相关性的影响。
Maturitas. 1995 Nov;22(3):239-46. doi: 10.1016/0378-5122(95)00942-e.
7
Phytotherapy versus hormonal therapy for postmenopausal bone loss: a meta-analysis.植物疗法与激素疗法治疗绝经后骨质疏松症：一项荟萃分析。
Osteoporos Int. 2009 Apr;20(4):519-26. doi: 10.1007/s00198-008-0724-x. Epub 2008 Sep 17.
8
Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use.西班牙的激素避孕与绝经后激素治疗：使用的时间趋势与模式
Menopause. 2015 Oct;22(10):1138-46. doi: 10.1097/GME.0000000000000487.
9
When is it safe to switch from oral contraceptives to hormonal replacement therapy?从口服避孕药转换为激素替代疗法何时才安全？
Contraception. 1995 Dec;52(6):371-6. doi: 10.1016/0010-7824(95)00229-4.
10
Effects of short-term hormone replacement on serum leptin levels in postmenopausal women.短期激素替代对绝经后女性血清瘦素水平的影响。
Clin Endocrinol (Oxf). 1999 Oct;51(4):415-22. doi: 10.1046/j.1365-2265.1999.00796.x.
引用本文的文献
1
Antiosteoporosis effect of bryodulcosigenin on ovariectomy-induced osteoporosis in experimental rats.苔藓 dulcosigenin 对实验性大鼠去卵巢诱导骨质疏松症的抗骨质疏松作用。
Acta Cir Bras. 2024 Apr 22;39:e391024. doi: 10.1590/acb391024. eCollection 2024.
2
A Novel Method to Differentiate Tonsil-Derived Mesenchymal Stem Cells In Vitro into Estrogen-Secreting Cells.一种新型方法可将扁桃体来源的间充质干细胞体外分化为分泌雌激素的细胞。
Tissue Eng Regen Med. 2021 Apr;18(2):253-264. doi: 10.1007/s13770-020-00307-y. Epub 2020 Oct 28.
本文引用的文献
1
Menopausal hormone therapy for the primary prevention of chronic conditions. U.S. Preventive Services Task Force recommendation statement.用于慢性病一级预防的绝经激素治疗。美国预防服务工作组建议声明。
Pol Arch Med Wewn. 2013;123(3):112-7. doi: 10.20452/pamw.1625. Epub 2013 Feb 11.
2
Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations.绝经激素治疗用于慢性疾病的一级预防：系统评价更新美国预防服务工作组的建议。
Ann Intern Med. 2012 Jul 17;157(2):104-13. doi: 10.7326/0003-4819-157-2-201207170-00466.
3
Long term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗。
Cochrane Database Syst Rev. 2012 Jul 11(7):CD004143. doi: 10.1002/14651858.CD004143.pub4.
4
Breast cancer after use of estrogen plus progestin in postmenopausal women.绝经后妇女使用雌激素加孕激素后发生的乳腺癌。
N Engl J Med. 2009 Feb 5;360(6):573-87. doi: 10.1056/NEJMoa0807684.
5
Ovarian cancer and hormone replacement therapy in the Million Women Study.“百万女性研究”中的卵巢癌与激素替代疗法
Lancet. 2007 May 19;369(9574):1703-10. doi: 10.1016/S0140-6736(07)60534-0.
6
Endometrial cancer and hormone-replacement therapy in the Million Women Study.百万女性研究中的子宫内膜癌与激素替代疗法
Lancet. 2005;365(9470):1543-51. doi: 10.1016/S0140-6736(05)66455-0.
7
Breast cancer and hormone-replacement therapy: the Million Women Study.乳腺癌与激素替代疗法：百万女性研究
Lancet. 2003 Oct 18;362(9392):1332; author reply 1332. doi: 10.1016/S0140-6736(03)14598-9.
8
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.健康绝经后妇女使用雌激素加孕激素的风险与益处：妇女健康倡议随机对照试验的主要结果
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
9
Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study.
Ann Intern Med. 2001 Jul 3;135(1):1-8. doi: 10.7326/0003-4819-135-1-200107030-00003.
10
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.雌激素加孕激素用于绝经后妇女冠心病二级预防的随机试验。心脏与雌激素/孕激素替代研究（HERS）研究组
JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605.
Zotero 插件